Kriti Nutrients Q1 FY27 Results (NSE: KRITINUT)
Signal: Growth decelerated
The read
The trajectory has shifted from Q4FY26's 27.6% revenue growth to 7.9% in Q1FY27: EBITDA margin recovered 185bps QoQ to 5.5% and raw-material intensity improved to 81.4%, but EBITDA grew only 0.4% and PAT fell 6.0% because operating growth remained weak and finance costs rose 106.4% YoY.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹247.08 Cr | 7.9% | -3.2% |
| EBIT | ₹11.96 Cr | -0.2% | |
| Net profit | ₹8.92 Cr | -6.0% | |
| EPS | ₹1.78 | -5.8% | |
| EBIT margin | 5.5% |
P&L walk
Consolidated revenue rose 7.9% YoY to ₹24707.76 lakh but EBITDA increased only 0.4% to ₹1348 lakh and EBIT declined 0.2% to ₹1196 lakh; lower raw-material intensity and a 185bps sequential margin recovery were insufficient to prevent PAT falling 6.0% to ₹891.85 lakh.
Key positives
- Raw-material cost declined to 81.4% of revenue from 85.6% YoY, while gross margin recovered 247bps QoQ to 9.8%.
- EBITDA margin improved to 5.5%, up 54bps YoY and 185bps QoQ, reversing the contraction seen through Q3FY26.
- Standalone and consolidated revenue and EBITDA were identical, showing no operating drag from the associate.
Key concerns
- Revenue growth decelerated to 7.9% YoY from 27.6% in Q4FY26, while EBITDA growth was only 0.4%.
- Consolidated PAT declined 6.0% YoY to ₹891.85 lakh despite the margin recovery.
- Finance costs increased 106.4% YoY to ₹23.81 lakh, indicating rising below-operating-line pressure.
Research and educational content only. Not investment advice.